Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

J Bellmunt, Ronald de Wit, DJ Vaughn, Y Fradet, JL Lee, L Fong, NJ Vogelzang, MA Climent, DP Petrylak, TK Choueiri, A Necchi, W Gerritsen, H Gurney, DI Quinn, S Culine, CN Sternberg, Y Mai, CH Poehlein, RF Perini, DF Bajorin

Research output: Contribution to journalArticleAcademicpeer-review

2555 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1015-1026
Number of pages12
JournalNew England Journal of Medicine
Issue number11
Publication statusPublished - 2017

Research programs

  • EMC OR-01

Cite this